XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
0.8400
-0.0514 (-5.77%)
At close: Feb 17, 2026, 4:00 PM EST
0.7190
-0.1210 (-14.40%)
After-hours: Feb 17, 2026, 7:57 PM EST
XTL Biopharmaceuticals Employees
XTL Biopharmaceuticals had 10 employees as of December 31, 2024. The number of employees increased by 3 or 42.86% compared to the previous year.
Employees
10
Change
3
Growth
42.86%
Revenue / Employee
$96,800
Profits / Employee
-$630,800
Market Cap
8.56M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 10 | 3 | 42.86% | 10 | 0 |
| Dec 31, 2016 | 7 | 1 | 16.67% | 2 | 5 |
| Dec 31, 2015 | 6 | 1 | 20.00% | 3 | 3 |
| Dec 31, 2014 | 5 | - | - | 3 | 2 |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 117 |
| CollPlant Biotechnologies | 57 |
| NuCana | 22 |
| SeaStar Medical Holding | 19 |
| Edesa Biotech | 17 |
| CalciMedica | 15 |
| TransCode Therapeutics | 7 |
| Ernexa Therapeutics | 6 |
XTLB News
- 19 days ago - XTL Update on Recent Developments - GlobeNewsWire
- 25 days ago - XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency - GlobeNewsWire
- 5 weeks ago - XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership - GlobeNewsWire
- 7 weeks ago - XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency - GlobeNewsWire
- 11 months ago - XTL Names Mr. Noam Band as its New Chief Executive Officer - GlobeNewsWire
- 1 year ago - XTL Completed the Acquisition of The Social Proxy and a Private Placement of $1.5 Million - GlobeNewsWire
- 1 year ago - XTL Entered Definitive Agreement to Acquire The Social Proxy - GlobeNewsWire
- 2 years ago - XTL To Aquire The Social Proxy - GlobeNewsWire